+Compare
SYNB
ETF ticker: NYSE ARCA
AS OF
Loading...
Price
Loading...
Change
Loading...
Net Assets
6.14M

SYNB Putnam BioRevolution ETF Forecast, Technical & Fundamental Analysis

Category Health
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for SYNB with price predictions
07:00 PM EST Nov 30, 2023

SYNB's RSI Indicator sits in overbought zone for 1 day

Watch for a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 03, 2023. You may want to consider a long position or call options on SYNB as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SYNB just turned positive on November 03, 2023. Looking at past instances where SYNB's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .

SYNB moved above its 50-day moving average on November 15, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SYNB crossed bullishly above the 50-day moving average on November 22, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SYNB advanced for three days, in of 71 cases, the price rose further within the following month. The odds of a continued upward trend are .

SYNB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 54 cases where SYNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOGL), NVIDIA Corp (NASDAQ:NVDA), Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), Chipotle Mexican Grill (NYSE:CMG), lululemon athletica (NASDAQ:LULU), Archer Daniels Midland Company (NYSE:ADM).

Industry description

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 122.55B. The market cap for tickers in the group ranges from 64.65K to 1.73T. GOOGL holds the highest valuation in this group at 1.73T. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 2%. For the same ETF, the average monthly price growth was 10%, and the average quarterly price growth was 0%. ASND experienced the highest price growth at 13%, while ARGX experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was 137%. For the same stocks of the ETF, the average monthly volume growth was -12% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 61
Price Growth Rating: 50
SMR Rating: 65
Profit Risk Rating: 60
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBB16.311.03
+6.74%
RBB Bancorp
EBON6.690.12
+1.83%
Ebang International Holdings
BLK756.355.12
+0.68%
Blackrock
FINV4.460.03
+0.68%
FinVolution Group
ABCM23.97N/A
N/A
Abcam plc

SYNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYNB has been closely correlated with IBB. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYNB jumps, then IBB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYNB
1D Price
Change %
SYNB100%
+0.98%
IBB - SYNB
80%
Closely correlated
+1.38%
VHT - SYNB
78%
Closely correlated
+0.65%
IHI - SYNB
72%
Closely correlated
+1.24%
XLV - SYNB
71%
Closely correlated
+0.40%
XBI - SYNB
67%
Closely correlated
+3.06%